Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Medical Countermeasures Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic FeverGlobal Biodefense StaffJune 5, 2025
NIAID Seeks Proposals for Broad Spectrum Biodefense Countermeasures Antimicrobial Resistance July 18, 2012 …
Army Award to UMass for Respiratory Pathogen Countermeasure Research Defense + Military July 12, 2012 …
Top Pharma and Research Institutes Partner for ‘TB Drug Accelerator’ Medical Countermeasures June 27, 2012 …
Emergent Biosolutions, Novartis, Texas A&M to Lead New Biodefense Centers Contracts + Grants June 19, 2012 …
